1. Malvi Reetesh K, Papiya B, Sunny S, Sonam J. Medicinal plants used in the treatment of epilepsy. IRJP. 2011;2:32–9.
2. Jackson MJ, Turkington D. Depression and anxiety in epilepsy. J Neurol Neurosurg Psychiatry. 2005;76:i45–7. [PMC free article] [PubMed] 3. Sander JW, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry. 1996;61:433–43. [PMC free article] [PubMed]
4. Sahstri R. Murchchha Rogadhikara. 15-21. Vol. 21. Varanasi: Chaukhambha Surbharati Prakashan; 2007. Bhaishajya Ratnavali; p. 499.
6. Ikemoto A, Nitta A, Furulwa S, Ohishi M, Nakamura A, Fujii Y, et al. Dietary omega 3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neurosci Lett. 2000;285:99–102. [PubMed] 7. Schlanger S, Shinitzky M, Yam D. Diet enriched with omega-3 fatty acids alleviates convulsion symptoms in epilepsy patients. Epilepsia. 2002;43:103–4. [PubMed]
8. Mostofsky DI, Rabinovitz S, Yehuda S. The use of fatty acid supplementation for seizure management. Neurobiol Lipids. 2004;3:17–23.
9. Dell CA, Likhodii SS, Musa K, Ryan MA, Burnham WM, Cunnane SC. Lipid and fatty acid profiles in rats consuming different high fat ketogenic diets. Lipids. 2001;36:373–8. [PubMed] 10. Søvik O, Mansson JE, Bjorke Monsen AL, Jellum E, Berge RK. Generalized peroxisomal disorder in male twins: Fatty acid composition of serum lipids and response to n-3 fatty acids. J Inherit Metab Dis. 1998;21:662–70. [PubMed] 11. Lauritzen I, Bloneau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuro protector. EMBO J. 2000;19:1784–93. [PubMed]
12. Bhavamishra, Nighantu B, Chunekar K. 9th ed. Varanasi: Chaukhambha Bharati Academy; 2006. p. 653.
13. Ministry of Health ' Family welfare. New Delhi: Dept. of AYUSH; 2003. Anonymous, the ayurvedic formulary of India, Part I. 2nd ed. Govt. of India; pp. 8–9.
14. Paget GE, Barnes JM. Evaluation of drug activities. In: Lawrence DR, Bacharach AL, editors. Pharmacometrics. Vol. 1. New York: Academic Press; 1964. p. 161.
15. Senthil Kumar KK, Rajkapoor B. Effect of oxalis corniculata extracts on biogenic amines concentrations in rat brain after induction of seizure. IJP. 2010;1:87–91.
16. Loscher W, Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 1988;2:145–81. [PubMed] 17. Kupferberg HJ. Antiepileptic drug development program: A cooperative effort of government and industry. Epilepsia. 1989;30:S51–6. [PubMed] 18. Goodman LS, Grewal MS, Brown WC, Swinyard EA. Comparison of maximal seizures evoked by pentylenetetrazol (Metrol) and electroshock in mice, and their modification by anticonvulsants. J Pharmacol Exp Ther. 1953;108:168–76. [PubMed] 19. White HS. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs. Epilepsia. 1997;38:S9–17. [PubMed]
20. McDonald RL, Kelly KM. Antiepileptic drugs: Mechanism of action. Epilespsia. 1991;34:51–8.
21. Kulkarni SK, George B. Anticonvulsant action of Withania somnifera root extract against pentylene tetrazole (PTZ)-induced convulsions in mice. Phytother Res. 1996;95:447–9.
22. Kulkarni SK, Sharma A, Verma A, Ticku MK. GABA receptor mediated anticonvulsant action of Withania somnifera root extract. IDMA. 1993:305–12.
23. Bhattacharya SK, Kumar A, Ghosal S. Effects of glycowithanolides from withania somnifera on an animal model of Alzheimer's disease and perturbed central cholinergic markers of cognition in rats. Phytother Res. 1995;9:110–3.
24. Bhattacharya SK, Satyan KS, Ghosal S. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Biol. 1997;35:236–9. [PubMed]
25. Mayur P, Pawan P, Ashwin S, Pravesh S. Evaluation of anti convulsant activity of roots & rhizomes of cyperus rotundus linn. in mice. IRJP. 2011;2:37–41.
26. Khalili M, Kiasalari Z, Roghani M, Azizi Y. Anticonvulsant and antioxidant effect of hydroalcoholic extract of Cyperus rotundus rhizome on pentylentetrazole-induced kindling model in male mice. JMPR. 2011;5:1140–6.
27. Srinivas V, Haranath Babu M, Narendra Reddy T, Diwan AV. Modulation of neuotransmitters in mice brains by an anticonvulsant principle from cuttle bone. Indian J Pharmacol. 1997;29:296–300.
28. Yu ZF, Kong LD, Chen Y. Antidepressant activity of aqueous extracts of Curcuma longa in mice. J Ethnopharmacol. 2002;83:161–5. [PubMed]
29. Jithendra C, Murthy TE, Upadyay L. Protective role of curcumin in maximal electroshock induced seizures, memory impairment and neurotransmitters in rat brain. JPCCR. 2008;2:35–9.
30. Du P, Li X, Lin HJ, Peng W, Liu JY, Ma Y, et al. Curcumin inhibits amygdaloid kindled seizures in rats. Chin Med J (Engl) 2009;122:1435–8. [PubMed]
31. Hogade Maheshwar G, Deshpande SV, Pramod HJ. Anticonvulsant activity of fruits of terminali chebula retz. against MES and PTZ induced seizures in rats. Journal of Herbal Medicine and Toxicology. 2010;4:123–6.
32. Debnath J, Sharma UR, Kumar B, Chauhan NS. Anticonvulsant activity of ethanolic extract of fruits of Terminalia Chebula on experimental animals. IJDDR, 2010;2:764–8.
33. Yende SR, Harle UN, Bore VV, Bajaj AO, Shroff KK, Vetal YD. Reversal of neurotoxicity induced cognitive impairment associated with phenytoin and phenobarbital by acorus calamus in mice. Journal of Herbal Medicine and Toxicology. 2009;3:111–5.
34. Gopalakrishna HN, Pemminati S, Giri S, Shenoy AK, Holla GK, Nair V, et al. Effect of Acorus Calamus on electrical and chemical induced seizures in mice. IJABPT. 2010;1:466–73.
35. Tripathi A, Patil MB, Tripathi R. Phytochemical investigation and anticonvulsant activity of acorus calamus. Int J Pharmacol Bio Sci. 2011;5:51–4.
36. Jayaraman R, Anitha T, Joshi VD. Analgesic and anticonvulsant effects of acorus calamus roots in mice. International Journal of PharmTech Research. 2010;2:552–5.
37. Pandey N, Tripathi YB. Antioxidant activity of tuberosin isolated from Pueraria tuberose Linn. J Inflamm. 2010;7:47. [PMC free article] [PubMed]
38. Basavaraj P, Shivakumar B, Shivakumar H. Evaluation of Anticonvulsant activity of alcoholic extract of tubers of Pueraria Tuberosa (Roxb) Adv Pharmacol Toxicol. 2011;12:1–9.
39. Kale Shubhangi S, Shete Rajkumar V, Kore Kakasaheb J, Patil Bhaskar M, Bhutada Rupesh N, Pattankude Vinod S. Anti convulsant activity of Glycyrrhizic acid in mice. IJPRD. 2010;2:16.
40. Ambawade SD, Kasture VS, Kasture SB. Anticonvulsant activity of roots and rhizomes of Glycyrrhiza glabra. Indian J Pharmacol. 2002;34:251–5.
41. Cys neiros RM, Ferrari D, Arida RM, Terra VC, de Almeida AC, Cavalheiro EA, et al. Qualitative analysis of hippocampal plastic changes in rats with epilepsy supplemented with oral omega 3 fatty acids. Epilepsy Behav. 2010;17:33–8. [PubMed] 42. Ferrari D, Cysneiros RM, Scorza CA. Neuroprotective activity of omega-3 fatty acids against epilepsy-induced hippocampal damage: Quantification with immunohistochemical for calcium-binding proteins. Epilepsy Behav. 2008;13:36–42. [PubMed] 43. Young C, Gean P, Chiou LC, Shen Y. Docosahexaenoic acid inhibits synaptic transmission and epileptiform activity in the rat hippocampus. Synapse. 2000;37:90–4. [PubMed] 44. Xiao YF, Kang JX, Morgan JP, Leaf A. Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A. 1995;92:11000–4. [PubMed] 45. Xiao Y, Li X. Polyunsatured fatty acids modify mouse hippocampal neuronal excitability during excitotoxic or convulsant stimulation. Brain Res. 1999;846:112–21. [PubMed] 46. Xiao YF, Gomez AM, Morgan JP, Lederer WJ, Leaf A. Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A. 1997;94:4182–7. [PubMed]